Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
Robocath successfully completes first robotic coronary angioplasties in Belgium
Lynred accueille une visite de la députée de l’Isère et le sous-préfet à la relance
NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors
Minagro’s co-formulant in-can preservative, Sovinol P740/O, gains Ecocert certification
Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology
Tollys appoints Amina Zinaï, MD, as head of clinical development
Calixar invests €1 Million in pipeline of highly druggable membrane protein targets and native antigens
